GATA6 Regulates Aortic Valve Remodeling, and Its Haploinsufficiency Leads to Right-Left Type Bicuspid Aortic Valve

Background: Bicuspid aortic valve (BAV), the most common congenital heart defect affecting 1% to 2% of the population, is a major risk factor for premature aortic valve disease and accounts for the majority of valve replacement. The genetic basis and mechanisms of BAV etiology and pathogenesis remain largely undefined. Methods: Cardiac structure and function was assessed in mice lacking a Gata6 allele. Human GATA6 gene variants were analyzed in 452 BAV cases from the BAV consortium and 1849 controls from the Framingham GWAS (Genome Wide Association Study). GATA6 expression was determined in mice and human tissues using quantitative real-time polymerase chain reaction and immunohistochemistry. Mechanistic studies were carried out in cultured cells. Results: Gata6 heterozygous mice have highly penetrant right-left (RL)-type BAV, the most frequent type in humans. GATA6 transcript levels are lower in human BAV compared with normal tricuspid valves. Mechanistically, Gata6 haploinsufficiency disrupts valve remodeling and extracellular matrix composition through dysregulation of important signaling molecules, including matrix metalloproteinase 9. Cell-specific inactivation of Gata6 reveals an essential role for GATA6 in secondary heart field myocytes because loss of 1 Gata6 allele from Isl-1-positive cells—but not from endothelial or neural crest cells—recapitulates the phenotype of Gata6 heterozygous mice. Conclusions: The data identify a new cellular and molecular mechanism underlying BAV. The availability of an animal model for the most frequent human BAV opens the way for the elucidation of BAV pathogenesis and the development of much needed therapies.

[1]  J. Redondo,et al.  Sequential Ligand-Dependent Notch Signaling Activation Regulates Valve Primordium Formation and Morphogenesis. , 2016, Circulation research.

[2]  R. McPherson,et al.  Endothelial Gata5 transcription factor regulates blood pressure , 2015, Nature Communications.

[3]  M. Cleman,et al.  Trends of Hospitalizations in the United States from 2000 to 2012 of Patients >60 Years With Aortic Valve Disease. , 2015, The American journal of cardiology.

[4]  Y. Bossé,et al.  The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives† , 2015, The journal of pathology. Clinical research.

[5]  Ronald Berezney,et al.  MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus , 2015, Human molecular genetics.

[6]  Y. Bossé,et al.  Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). , 2014, Circulation.

[7]  K. McBride,et al.  Rare GATA5 sequence variants identified in individuals with bicuspid aortic valve , 2014, Pediatric Research.

[8]  Michael Markl,et al.  Bicuspid Aortic Cusp Fusion Morphology Alters Aortic Three-Dimensional Outflow Patterns, Wall Shear Stress, and Expression of Aortopathy , 2014, Circulation.

[9]  F. Shen,et al.  GATA6 predicts prognosis and hepatic metastasis of colorectal cancer. , 2013, Oncology reports.

[10]  H. Dietz,et al.  Genotype-phenotype correlation in patients with bicuspid aortic valve and aneurysm. , 2013, The Journal of thoracic and cardiovascular surgery.

[11]  F. Quintero-Rivera,et al.  First report of a de novo 18q11.2 microdeletion including GATA6 associated with complex congenital heart disease and renal abnormalities , 2013, American journal of medical genetics. Part A.

[12]  Chien-Liang Wu,et al.  Circulating Matrix Metalloproteinase-2 and -9 Enzyme Activities in the Children with Ventricular Septal Defect , 2013, International journal of biological sciences.

[13]  J. Friedland-Little,et al.  Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation. , 2012, Developmental cell.

[14]  D. Sela-Donenfeld,et al.  Matrix metalloproteinase 9/gelatinase B is required for neural crest cell migration. , 2012, Developmental biology.

[15]  Brigitte Laforest,et al.  GATA5 interacts with GATA4 and GATA6 in outflow tract development. , 2011, Developmental biology.

[16]  G. Andelfinger,et al.  Loss of Gata5 in mice leads to bicuspid aortic valve. , 2011, The Journal of clinical investigation.

[17]  H. Schäfers,et al.  Valve Configuration Determines Long-Term Results After Repair of the Bicuspid Aortic Valve , 2011, Circulation.

[18]  J. Epstein,et al.  Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. , 2011, The Journal of clinical investigation.

[19]  B. Aronow,et al.  The Transcription Factor GATA-6 Regulates Pathological Cardiac Hypertrophy , 2010, Circulation research.

[20]  Y. Liu,et al.  A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect , 2010, Journal of Human Genetics.

[21]  J. Lincoln,et al.  Reduced Sox9 Function Promotes Heart Valve Calcification Phenotypes In Vivo , 2010, Circulation research.

[22]  A. C. Durán,et al.  Bicuspid aortic valves with different spatial orientations of the leaflets are distinct etiological entities. , 2009, Journal of the American College of Cardiology.

[23]  R. Markwald,et al.  Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. , 2009, Physiological genomics.

[24]  M. Furutani,et al.  GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling , 2009, Proceedings of the National Academy of Sciences.

[25]  B. Black,et al.  BMP4 is required in the anterior heart field and its derivatives for endocardial cushion remodeling, outflow tract septation, and semilunar valve development , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[26]  C M Otto,et al.  The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape , 2008, Heart.

[27]  J. Elefteriades,et al.  Bicuspid aortic valve: clinical approach and scientific review of a common clinical entity , 2008, Expert review of cardiovascular therapy.

[28]  Paul Khairy,et al.  Bicuspid aortic valve morphology and interventions in the young. , 2007, Journal of the American College of Cardiology.

[29]  R. Hinton,et al.  Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations , 2007, Human Genetics.

[30]  L. Lau,et al.  The Matricellular Protein CCN1 Is Essential for Cardiac Development , 2006, Circulation research.

[31]  C. Lien,et al.  A threshold of GATA4 and GATA6 expression is required for cardiovascular development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[33]  M. Lu,et al.  GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. , 2006, The Journal of clinical investigation.

[34]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[35]  Robert H. Anderson,et al.  Lineage and Morphogenetic Analysis of the Cardiac Valves , 2004, Circulation research.

[36]  M. Nemer,et al.  Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6. , 2003, Developmental biology.

[37]  R. Patient,et al.  Widespread expression of an extended peptide sequence of GATA-6 during murine embryogenesis and non-equivalence of RNA and protein expression domains , 2002, Mechanisms of Development.

[38]  M. Nemer,et al.  Cooperative interaction between GATA5 and NF-ATc regulates endothelial-endocardial differentiation of cardiogenic cells. , 2002, Development.

[39]  J. Pfeilschifter,et al.  Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. , 2002, Molecular endocrinology.

[40]  J. Epstein,et al.  Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. , 2001, Development.

[41]  D. Stewart,et al.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. , 2000, Circulation.

[42]  A. Gallego,et al.  Coronary artery anomalies and aortic valve morphology in the Syrian hamster , 2000, Laboratory animals.

[43]  B. Hogan,et al.  The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. , 1999, Development.

[44]  Ada Hamosh,et al.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene , 1991, Nature.

[45]  M. Kirby,et al.  Neural crest cells contribute to normal aorticopulmonary septation. , 1983, Science.

[46]  C. Newton-Cheh,et al.  The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association study. , 2017, Journal of Molecular and Cellular Cardiology.